Last reviewed · How we verify
NCT03832023: CONTACT
Community-based Tuberculosis Tracing and Preventive Therapy
NA trial testing Screening and initiating preventive therapy in communities in Tuberculosis in 1,400 participants. Completed in 1 August 2022.
1 August 2022
Quick facts
| Lead sponsor | Elizabeth Glaser Pediatric AIDS Foundation |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 1,400 |
| Start date | 14 October 2019 |
| Primary completion | 1 August 2022 |
| Estimated completion | 1 August 2022 |
| Sites | 25 locations across Cameroon, Uganda |
Drugs / interventions tested
- Screening and initiating preventive therapy in communities
Conditions studied
- Tuberculosis — all drugs for Tuberculosis →
Sponsor
Elizabeth Glaser Pediatric AIDS Foundation
Who can join
Eligibility, any sex, with Tuberculosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The many gaps observed in the cascade of care of tuberculosis (TB) child contacts occur mostly in the screening, preventive therapy (PT) initiation and PT completion steps and the main drivers of these gaps are considered to be the health system infrastructure, limited worker resources and parents' reluctance to bring their children to the facility for screening. There would be great advantages of using a symptom-based screening at community level where only the symptomatic contacts are referred to hospital for further evaluation and asymptomatic contacts are started on PT in the community. Household or community-based screening is likely to improve the uptake and acceptability of child contact screening and management as well as adherence to PT and to reduce cost and workload at facility level. This study proposes to compare the cascade of care between two models for TB screening and management of household TB child contacts in two high TB burden and limited resource countries, Cameroon and Uganda. In the facility-based model, children will be screened at facility (Cameroon) or household level (Uganda) and preventive therapy initiation, refills of PT therapy and follow-up will be done at facility level. In the intervention group (community-based model), child contacts will be screened in the household by a community health worker (CHW). Those with symptoms suggestive of TB will be referred to the facility for TB investigations. Asymptomatic child contacts from high risk groups (under-5 years or HIV infected 5-14) will be initiated on PT (3 months isoniazid-rifampicin) in the household. Refills of PT therapy will also be done in the communities by the CHW. In both models, symptomatic children requiring further investigations for TB diagnosis will be referred to a health facility.
Publications & conference data
5 peer-reviewed publications reference this trial (live from Europe PMC):
-
Effectiveness of a community-based approach for the investigation and management of children with household tuberculosis contact in Cameroon and Uganda: a cluster-randomised trial.
Bonnet M, Vasiliu A, Tchounga BK, Cuer B, et al · · 2023 · cited 23× · PMID 37918417 · DOI 10.1016/s2214-109x(23)00430-8 -
Feasibility of a randomized clinical trial evaluating a community intervention for household tuberculosis child contact management in Cameroon and Uganda.
Vasiliu A, Tiendrebeogo G, Awolu MM, Akatukwasa C, et al · · 2022 · cited 8× · PMID 35148800 · DOI 10.1186/s40814-022-00996-3 -
Community intervention for child tuberculosis active contact investigation and management: study protocol for a parallel cluster randomized controlled trial.
Vasiliu A, Eymard-Duvernay S, Tchounga B, Atwine D, et al · · 2021 · cited 8× · PMID 33653385 · DOI 10.1186/s13063-021-05124-9 -
Cost-effectiveness analysis of interventions to improve diagnosis and preventive therapy for paediatric tuberculosis in 9 sub-Saharan African countries: A modelling study.
Mafirakureva N, Mukherjee S, de Souza M, Kelly-Cirino C, et al · · 2023 · cited 7× · PMID 37672524 · DOI 10.1371/journal.pmed.1004285 -
Feasibility of a randomized clinical trial evaluating a community intervention for household tuberculosis child contact management in Cameroon and Uganda
Vasiliu A, Tiendrebeogo G, Awolu MM, Akatukwasa C, et al · · 2021 · DOI 10.21203/rs.3.rs-970700/v1
Verify or expand the search:
- PubMed search for NCT03832023
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Tuberculosis
Currently open trials in the same condition.
- NCT05917210 — Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda · NA · recruiting
- NCT07170735 — Quantitative Measurement of Plasma and Urine MTB Cell-free DNA Level · recruiting
- NCT07484490 — Effects of the Active Cycle of Breathing Technique With and Without Balloon Blowing Therapy in Tuberculosis · NA · recruiting
- NCT06318416 — Precision Rifampin Trial for Personalized Dosing · Phase 1 · recruiting
- NCT07170800 — A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets · Phase 2 · recruiting
Other Elizabeth Glaser Pediatric AIDS Foundation trials
Trials by the same sponsor.
- NCT05684887 — Digital Tools to Expand COVID-19 Testing in Exposed Individuals in Cameroon · NA · completed
- NCT05529771 — Clinical Outcomes of paTients pREsenting to HArare COVID-19 CenTer of Excellence With SARS-CoV-2 Infection · completed
- NCT05458557 — Antigen Rapid Diagnostic Tests for Community Identification of Severe Acute Respiratory Syndrome Coronavirus 2 · completed
- NCT05382130 — INTEGrating Ag-RDTs for COVID-19 in MNCH,HIV and TB Services in Cameroon and Kenya · NA · completed
- NCT05498727 — Evaluation of the Integration of Ag-RDTs for COVID-19 in MNCH, HIV and TB Services in Cameroon and Kenya · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03832023 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Elizabeth Glaser Pediatric AIDS Foundation
- Last refreshed: 16 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03832023.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing